Furthermore, blocking the activation of the VEGF receptor VEGFR2 limited lesion formation and bleeding in a mouse model of CCM (69), suggesting that down-regulation of the β-catenin∙VE-cadherin complex may be a critical signal in CCM pathogenesis. Here, CDH17 is linked to cerebral cavernous malformation.